Clinical Trial Update: Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses [NA]

View source ↗

Summary

Completed clinical trial evaluating the safety and efficacy of TwHF (Tripterygium wilfordii) in HIV patients with poor immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TwHF (Tripterygium wilfordii) (Tripterygium wilfordii)

Snippet

Sponsor: LI Taisheng | Conditions: HIV | NA | Status: COMPLETED